Patent details
EP2190429
Title:
A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS
Basic Information
- Publication number:
- EP2190429
- PCT Application Number:
- PCT/US/2008/075903
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP088306196
- PCT Publication Number:
- WO/2009/036099
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS
- French Title of Invention:
- GROUPE INNOVANT D'INHIBITEURS DE LA VOIE STAT3 ET D'INHIBITEURS DE LA VOIE DES CELLULES SOUCHES CANCÉREUSES
- German Title of Invention:
- NEUE GRUPPE VON STAT3-PFAD-HEMMERN UND KREBS-STAMMZELL-PFAD-HEMMER
- SPC Number:
-
Dates
- Filing date:
- 10/09/2008
- Grant date:
- 20/04/2016
- EP Publication Date:
- 20/04/2016
- PCT Publication Date:
- 19/03/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/06/2010
- EP B1 Publication Date:
- 20/04/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/09/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/09/2008
-
-
- Name:
- Boston Biomedical Inc.
- Address:
- 640 Memorial Drive, Cambridge, MA 02139, United States (US)
Agent
- Name:
- STOLMÁR & PARTNER
- From:
- 19/04/2016
- Address:
- BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
- To:
Inventor
1
- Name:
- JIANG Zhiwei
- Address:
- United States (US)
2
- Name:
- LI Youzhi
- Address:
- United States (US)
3
- Name:
- LI Chiang, Jia
- Address:
- United States (US)
4
- Name:
- LIU Jifeng
- Address:
- United States (US)
5
- Name:
- LI Wei
- Address:
- United States (US)
6
- Name:
- ROGOFF Harry
- Address:
- United States (US)
Priority
1
- Priority Number:
- 971144 P
- Priority Date:
- 10/09/2007
- Priority Country:
- United States (US)
2
- Priority Number:
- 13372
- Priority Date:
- 13/12/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 31/505;
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 09/09/2025
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- Beijing Guozhuan Intellectual Property Ltd
| Filing date |
Document type |
Number of pages |